FBI records and a National Archives clip show Anoka officers observed an unexplained multicolored object on Feb. 19, 2025. The sighting remains unresolved.

FDA advisers will vote this week on whether to switch the 2026–27 COVID booster to target XFG, a subvariant with immune‑evasive mutations.

FAA cleared Blue Origin’s New Glenn to return to flight; NG‑4 could launch from the Space Coast as early as June 4 carrying 48 Amazon Leo satellites.

Tampa-based Trace Systems won a 10-year, roughly $1.8B USSOCOM EAGLE‑I award to modernize C2ISR and multi-domain data transport.

High Tech High’s Holy Cows were part of the winning alliance at the 2026 FIRST Robotics world championship in Houston after a season of district awards and engineering honors.

A KB4‑CON demonstrator in Orlando showed how public video can be used to synthesize a local anchor’s speech, unnerving attendees and prompting legal and newsroom questions.

Portland State chemists report T111 cleared malaria stages in lab and animal tests, suggesting a single‑encounter cure could be possible.

Arizona will lead NNME Southwest, coordinating training and employer partners across five states to tackle a projected shortfall in chip industry workers.

VectorBuilder plans a $50M, 35,000‑sq‑ft R&D lab on Chicago’s South Side, targeting a 2027 opening and expanding the city’s CDMO capacity.

Scottsdale will use Motorola HYPER to handle routine non-emergency police calls, aiming to cut hold times while keeping human dispatchers focused on 911. The city says training and a phased rollout are already underway.

Gilead’s Hepcludex won FDA accelerated approval on May 22, 2026 — the first U.S. therapy for chronic hepatitis D — as Mirum and Vir push rival candidates toward late‑stage results.

Golden-based Lunar Outpost says its Pegasus rover was chosen by NASA to help explore and prepare the lunar south pole. The move pairs the startup with big industry partners.

Interim data show a single infusion of a PCSK9 base editor sharply lowered LDL in an early trial, while Cleveland researchers link low nitric oxide to altered gene splicing in Alzheimer’s. Clinicians warned that supplements aren’t regulated like drugs and can carry risks.